BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20179157)

  • 21. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.
    Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W
    J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.
    Liu Q; Rehman H; Shi Y; Krishnasamy Y; Lemasters JJ; Smith CD; Zhong Z
    PLoS One; 2012; 7(7):e41834. PubMed ID: 22848628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    J Biol Chem; 2006 Mar; 281(13):8518-27. PubMed ID: 16415355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
    Britten CD; Garrett-Mayer E; Chin SH; Shirai K; Ogretmen B; Bentz TA; Brisendine A; Anderton K; Cusack SL; Maines LW; Zhuang Y; Smith CD; Thomas MB
    Clin Cancer Res; 2017 Aug; 23(16):4642-4650. PubMed ID: 28420720
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
    Evangelisti C; Evangelisti C; Teti G; Chiarini F; Falconi M; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Beak DJ; Bittman R; Pyne S; Pyne NJ; Martelli AM
    Oncotarget; 2014 Sep; 5(17):7886-901. PubMed ID: 25226616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
    Chumanevich AA; Poudyal D; Cui X; Davis T; Wood PA; Smith CD; Hofseth LJ
    Carcinogenesis; 2010 Oct; 31(10):1787-93. PubMed ID: 20688834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
    Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
    Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection.
    Al-Shujairi WH; Clarke JN; Davies LT; Pitman MR; Calvert JK; Aloia AL; Pitson SM; Carr JM
    J Gen Virol; 2019 Apr; 100(4):629-641. PubMed ID: 30869582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.
    Lewis CS; Voelkel-Johnson C; Smith CD
    Oncotarget; 2016 Sep; 7(37):60181-60192. PubMed ID: 27517489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.
    Dai L; Smith CD; Foroozesh M; Miele L; Qin Z
    Int J Cancer; 2018 May; 142(10):2153-2162. PubMed ID: 29277894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1.
    LeBlanc FR; Pearson JM; Tan SF; Cheon H; Xing JC; Dunton W; Feith DJ; Loughran TP
    Br J Haematol; 2020 Aug; 190(3):405-417. PubMed ID: 32124438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Native and Polyubiquitinated Forms of Dihydroceramide Desaturase Are Differentially Linked to Human Embryonic Kidney Cell Survival.
    Alsanafi M; Kelly SL; Jubair K; McNaughton M; Tate RJ; Merrill AH; Pyne S; Pyne NJ
    Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
    Gao P; Peterson YK; Smith RA; Smith CD
    PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression.
    Hasanifard L; Samadi N; Rashtchizadeh N; Dastmalchi S; Karimi P
    Drug Res (Stuttg); 2018 Jan; 68(1):45-53. PubMed ID: 28950390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
    Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
    Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival.
    Gestaut MM; Antoon JW; Burow ME; Beckman BS
    Pharmacol Rep; 2014 Feb; 66(1):174-8. PubMed ID: 24905325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.
    Antoon JW; White MD; Driver JL; Burow ME; Beckman BS
    Exp Biol Med (Maywood); 2012 Jul; 237(7):832-44. PubMed ID: 22859737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
    Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preconditioning stimuli induce autophagy via sphingosine kinase 2 in mouse cortical neurons.
    Sheng R; Zhang TT; Felice VD; Qin T; Qin ZH; Smith CD; Sapp E; Difiglia M; Waeber C
    J Biol Chem; 2014 Jul; 289(30):20845-57. PubMed ID: 24928515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.